Global Hematopoietic Progenitor Cells Transplantation Supply, Demand and Key Producers, 2023-2029

Global Hematopoietic Progenitor Cells Transplantation Supply, Demand and Key Producers, 2023-2029

Page: 110

Published Date: 19 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Hematopoietic Progenitor Cells Transplantation market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Hematopoietic Progenitor Cells Transplantation demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hematopoietic Progenitor Cells Transplantation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hematopoietic Progenitor Cells Transplantation that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hematopoietic Progenitor Cells Transplantation total market, 2018-2029, (USD Million)
Global Hematopoietic Progenitor Cells Transplantation total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Hematopoietic Progenitor Cells Transplantation total market, key domestic companies and share, (USD Million)
Global Hematopoietic Progenitor Cells Transplantation revenue by player and market share 2018-2023, (USD Million)
Global Hematopoietic Progenitor Cells Transplantation total market by Type, CAGR, 2018-2029, (USD Million)
Global Hematopoietic Progenitor Cells Transplantation total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Hematopoietic Progenitor Cells Transplantation market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies, Vcanbio, Merck Millipore, Lonza Group and CellGenix Technologie Transfer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hematopoietic Progenitor Cells Transplantation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Hematopoietic Progenitor Cells Transplantation Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hematopoietic Progenitor Cells Transplantation Market, Segmentation by Type
Hematopoietic Progenitor Cell Storage
Hematopoietic Progenitor Cells Consumables

Global Hematopoietic Progenitor Cells Transplantation Market, Segmentation by Application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders

Companies Profiled:
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis

Key Questions Answered
1. How big is the global Hematopoietic Progenitor Cells Transplantation market?
2. What is the demand of the global Hematopoietic Progenitor Cells Transplantation market?
3. What is the year over year growth of the global Hematopoietic Progenitor Cells Transplantation market?
4. What is the total value of the global Hematopoietic Progenitor Cells Transplantation market?
5. Who are the major players in the global Hematopoietic Progenitor Cells Transplantation market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Hematopoietic Progenitor Cells Transplantation Introduction
1.2 World Hematopoietic Progenitor Cells Transplantation Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Hematopoietic Progenitor Cells Transplantation Total Market by Region (by Headquarter Location)
1.3.1 World Hematopoietic Progenitor Cells Transplantation Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.3 China Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.4 Europe Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.5 Japan Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.6 South Korea Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.7 ASEAN Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.8 India Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hematopoietic Progenitor Cells Transplantation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hematopoietic Progenitor Cells Transplantation Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.2 World Hematopoietic Progenitor Cells Transplantation Consumption Value by Region
2.2.1 World Hematopoietic Progenitor Cells Transplantation Consumption Value by Region (2018-2023)
2.2.2 World Hematopoietic Progenitor Cells Transplantation Consumption Value Forecast by Region (2024-2029)
2.3 United States Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.4 China Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.5 Europe Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.6 Japan Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.7 South Korea Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.8 ASEAN Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.9 India Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)

3 World Hematopoietic Progenitor Cells Transplantation Companies Competitive Analysis
3.1 World Hematopoietic Progenitor Cells Transplantation Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Hematopoietic Progenitor Cells Transplantation Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Hematopoietic Progenitor Cells Transplantation in 2022
3.2.3 Global Concentration Ratios (CR8) for Hematopoietic Progenitor Cells Transplantation in 2022
3.3 Hematopoietic Progenitor Cells Transplantation Company Evaluation Quadrant
3.4 Hematopoietic Progenitor Cells Transplantation Market: Overall Company Footprint Analysis
3.4.1 Hematopoietic Progenitor Cells Transplantation Market: Region Footprint
3.4.2 Hematopoietic Progenitor Cells Transplantation Market: Company Product Type Footprint
3.4.3 Hematopoietic Progenitor Cells Transplantation Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Hematopoietic Progenitor Cells Transplantation Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Hematopoietic Progenitor Cells Transplantation Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Hematopoietic Progenitor Cells Transplantation Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Hematopoietic Progenitor Cells Transplantation Consumption Value Comparison
4.2.1 United States VS China: Hematopoietic Progenitor Cells Transplantation Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hematopoietic Progenitor Cells Transplantation Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Hematopoietic Progenitor Cells Transplantation Companies and Market Share, 2018-2023
4.3.1 United States Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023)
4.4 China Based Companies Hematopoietic Progenitor Cells Transplantation Revenue and Market Share, 2018-2023
4.4.1 China Based Hematopoietic Progenitor Cells Transplantation Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023)
4.5 Rest of World Based Hematopoietic Progenitor Cells Transplantation Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Hematopoietic Progenitor Cells Transplantation Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hematopoietic Progenitor Cell Storage
5.2.2 Hematopoietic Progenitor Cells Consumables
5.3 Market Segment by Type
5.3.1 World Hematopoietic Progenitor Cells Transplantation Market Size by Type (2018-2023)
5.3.2 World Hematopoietic Progenitor Cells Transplantation Market Size by Type (2024-2029)
5.3.3 World Hematopoietic Progenitor Cells Transplantation Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Hematopoietic Progenitor Cells Transplantation Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Leukemia
6.2.2 Lymphoproliferative Disorders
6.2.3 Solid Tumors
6.2.4 Non-Malignant Disorders
6.2.5 Non-Malignant Disorders
6.3 Market Segment by Application
6.3.1 World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2018-2023)
6.3.2 World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2024-2029)
6.3.3 World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2018-2029)

7 Company Profiles
7.1 CBR Systems
7.1.1 CBR Systems Details
7.1.2 CBR Systems Major Business
7.1.3 CBR Systems Hematopoietic Progenitor Cells Transplantation Product and Services
7.1.4 CBR Systems Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 CBR Systems Recent Developments/Updates
7.1.6 CBR Systems Competitive Strengths & Weaknesses
7.2 China Cord Blood Corporation
7.2.1 China Cord Blood Corporation Details
7.2.2 China Cord Blood Corporation Major Business
7.2.3 China Cord Blood Corporation Hematopoietic Progenitor Cells Transplantation Product and Services
7.2.4 China Cord Blood Corporation Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 China Cord Blood Corporation Recent Developments/Updates
7.2.6 China Cord Blood Corporation Competitive Strengths & Weaknesses
7.3 ViaCord
7.3.1 ViaCord Details
7.3.2 ViaCord Major Business
7.3.3 ViaCord Hematopoietic Progenitor Cells Transplantation Product and Services
7.3.4 ViaCord Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 ViaCord Recent Developments/Updates
7.3.6 ViaCord Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Hematopoietic Progenitor Cells Transplantation Product and Services
7.4.4 Thermo Fisher Scientific Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 STEMCELL Technologies
7.5.1 STEMCELL Technologies Details
7.5.2 STEMCELL Technologies Major Business
7.5.3 STEMCELL Technologies Hematopoietic Progenitor Cells Transplantation Product and Services
7.5.4 STEMCELL Technologies Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 STEMCELL Technologies Recent Developments/Updates
7.5.6 STEMCELL Technologies Competitive Strengths & Weaknesses
7.6 Vcanbio
7.6.1 Vcanbio Details
7.6.2 Vcanbio Major Business
7.6.3 Vcanbio Hematopoietic Progenitor Cells Transplantation Product and Services
7.6.4 Vcanbio Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Vcanbio Recent Developments/Updates
7.6.6 Vcanbio Competitive Strengths & Weaknesses
7.7 Merck Millipore
7.7.1 Merck Millipore Details
7.7.2 Merck Millipore Major Business
7.7.3 Merck Millipore Hematopoietic Progenitor Cells Transplantation Product and Services
7.7.4 Merck Millipore Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Millipore Recent Developments/Updates
7.7.6 Merck Millipore Competitive Strengths & Weaknesses
7.8 Lonza Group
7.8.1 Lonza Group Details
7.8.2 Lonza Group Major Business
7.8.3 Lonza Group Hematopoietic Progenitor Cells Transplantation Product and Services
7.8.4 Lonza Group Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Lonza Group Recent Developments/Updates
7.8.6 Lonza Group Competitive Strengths & Weaknesses
7.9 CellGenix Technologie Transfer
7.9.1 CellGenix Technologie Transfer Details
7.9.2 CellGenix Technologie Transfer Major Business
7.9.3 CellGenix Technologie Transfer Hematopoietic Progenitor Cells Transplantation Product and Services
7.9.4 CellGenix Technologie Transfer Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 CellGenix Technologie Transfer Recent Developments/Updates
7.9.6 CellGenix Technologie Transfer Competitive Strengths & Weaknesses
7.10 ThermoGenesis
7.10.1 ThermoGenesis Details
7.10.2 ThermoGenesis Major Business
7.10.3 ThermoGenesis Hematopoietic Progenitor Cells Transplantation Product and Services
7.10.4 ThermoGenesis Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 ThermoGenesis Recent Developments/Updates
7.10.6 ThermoGenesis Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Hematopoietic Progenitor Cells Transplantation Industry Chain
8.2 Hematopoietic Progenitor Cells Transplantation Upstream Analysis
8.3 Hematopoietic Progenitor Cells Transplantation Midstream Analysis
8.4 Hematopoietic Progenitor Cells Transplantation Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Hematopoietic Progenitor Cells Transplantation Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Hematopoietic Progenitor Cells Transplantation Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Hematopoietic Progenitor Cells Transplantation Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Hematopoietic Progenitor Cells Transplantation Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Hematopoietic Progenitor Cells Transplantation Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Hematopoietic Progenitor Cells Transplantation Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Hematopoietic Progenitor Cells Transplantation Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Hematopoietic Progenitor Cells Transplantation Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Hematopoietic Progenitor Cells Transplantation Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Hematopoietic Progenitor Cells Transplantation Players in 2022
Table 12. World Hematopoietic Progenitor Cells Transplantation Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Hematopoietic Progenitor Cells Transplantation Company Evaluation Quadrant
Table 14. Head Office of Key Hematopoietic Progenitor Cells Transplantation Player
Table 15. Hematopoietic Progenitor Cells Transplantation Market: Company Product Type Footprint
Table 16. Hematopoietic Progenitor Cells Transplantation Market: Company Product Application Footprint
Table 17. Hematopoietic Progenitor Cells Transplantation Mergers & Acquisitions Activity
Table 18. United States VS China Hematopoietic Progenitor Cells Transplantation Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Hematopoietic Progenitor Cells Transplantation Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (States, Country)
Table 21. United States Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Hematopoietic Progenitor Cells Transplantation Revenue Market Share (2018-2023)
Table 23. China Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (Province, Country)
Table 24. China Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Hematopoietic Progenitor Cells Transplantation Revenue Market Share (2018-2023)
Table 26. Rest of World Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Hematopoietic Progenitor Cells Transplantation Revenue Market Share (2018-2023)
Table 29. World Hematopoietic Progenitor Cells Transplantation Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Hematopoietic Progenitor Cells Transplantation Market Size by Type (2018-2023) & (USD Million)
Table 31. World Hematopoietic Progenitor Cells Transplantation Market Size by Type (2024-2029) & (USD Million)
Table 32. World Hematopoietic Progenitor Cells Transplantation Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2018-2023) & (USD Million)
Table 34. World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2024-2029) & (USD Million)
Table 35. CBR Systems Basic Information, Area Served and Competitors
Table 36. CBR Systems Major Business
Table 37. CBR Systems Hematopoietic Progenitor Cells Transplantation Product and Services
Table 38. CBR Systems Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. CBR Systems Recent Developments/Updates
Table 40. CBR Systems Competitive Strengths & Weaknesses
Table 41. China Cord Blood Corporation Basic Information, Area Served and Competitors
Table 42. China Cord Blood Corporation Major Business
Table 43. China Cord Blood Corporation Hematopoietic Progenitor Cells Transplantation Product and Services
Table 44. China Cord Blood Corporation Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. China Cord Blood Corporation Recent Developments/Updates
Table 46. China Cord Blood Corporation Competitive Strengths & Weaknesses
Table 47. ViaCord Basic Information, Area Served and Competitors
Table 48. ViaCord Major Business
Table 49. ViaCord Hematopoietic Progenitor Cells Transplantation Product and Services
Table 50. ViaCord Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. ViaCord Recent Developments/Updates
Table 52. ViaCord Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Hematopoietic Progenitor Cells Transplantation Product and Services
Table 56. Thermo Fisher Scientific Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. STEMCELL Technologies Basic Information, Area Served and Competitors
Table 60. STEMCELL Technologies Major Business
Table 61. STEMCELL Technologies Hematopoietic Progenitor Cells Transplantation Product and Services
Table 62. STEMCELL Technologies Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. STEMCELL Technologies Recent Developments/Updates
Table 64. STEMCELL Technologies Competitive Strengths & Weaknesses
Table 65. Vcanbio Basic Information, Area Served and Competitors
Table 66. Vcanbio Major Business
Table 67. Vcanbio Hematopoietic Progenitor Cells Transplantation Product and Services
Table 68. Vcanbio Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Vcanbio Recent Developments/Updates
Table 70. Vcanbio Competitive Strengths & Weaknesses
Table 71. Merck Millipore Basic Information, Area Served and Competitors
Table 72. Merck Millipore Major Business
Table 73. Merck Millipore Hematopoietic Progenitor Cells Transplantation Product and Services
Table 74. Merck Millipore Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Merck Millipore Recent Developments/Updates
Table 76. Merck Millipore Competitive Strengths & Weaknesses
Table 77. Lonza Group Basic Information, Area Served and Competitors
Table 78. Lonza Group Major Business
Table 79. Lonza Group Hematopoietic Progenitor Cells Transplantation Product and Services
Table 80. Lonza Group Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Lonza Group Recent Developments/Updates
Table 82. Lonza Group Competitive Strengths & Weaknesses
Table 83. CellGenix Technologie Transfer Basic Information, Area Served and Competitors
Table 84. CellGenix Technologie Transfer Major Business
Table 85. CellGenix Technologie Transfer Hematopoietic Progenitor Cells Transplantation Product and Services
Table 86. CellGenix Technologie Transfer Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. CellGenix Technologie Transfer Recent Developments/Updates
Table 88. ThermoGenesis Basic Information, Area Served and Competitors
Table 89. ThermoGenesis Major Business
Table 90. ThermoGenesis Hematopoietic Progenitor Cells Transplantation Product and Services
Table 91. ThermoGenesis Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Hematopoietic Progenitor Cells Transplantation Upstream (Raw Materials)
Table 93. Hematopoietic Progenitor Cells Transplantation Typical Customers
List of Figure
Figure 1. Hematopoietic Progenitor Cells Transplantation Picture
Figure 2. World Hematopoietic Progenitor Cells Transplantation Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hematopoietic Progenitor Cells Transplantation Total Market Size (2018-2029) & (USD Million)
Figure 4. World Hematopoietic Progenitor Cells Transplantation Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Hematopoietic Progenitor Cells Transplantation Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 13. Hematopoietic Progenitor Cells Transplantation Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 16. World Hematopoietic Progenitor Cells Transplantation Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 18. China Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 23. India Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Hematopoietic Progenitor Cells Transplantation by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Hematopoietic Progenitor Cells Transplantation Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Hematopoietic Progenitor Cells Transplantation Markets in 2022
Figure 27. United States VS China: Hematopoietic Progenitor Cells Transplantation Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hematopoietic Progenitor Cells Transplantation Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Hematopoietic Progenitor Cells Transplantation Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Hematopoietic Progenitor Cells Transplantation Market Size Market Share by Type in 2022
Figure 31. Hematopoietic Progenitor Cell Storage
Figure 32. Hematopoietic Progenitor Cells Consumables
Figure 33. World Hematopoietic Progenitor Cells Transplantation Market Size Market Share by Type (2018-2029)
Figure 34. World Hematopoietic Progenitor Cells Transplantation Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Hematopoietic Progenitor Cells Transplantation Market Size Market Share by Application in 2022
Figure 36. Leukemia
Figure 37. Lymphoproliferative Disorders
Figure 38. Solid Tumors
Figure 39. Non-Malignant Disorders
Figure 40. Hematopoietic Progenitor Cells Transplantation Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Hematopoietic Progenitor Cells Transplantation Supply, Demand and Key Producers, 2023-2029

Global Hematopoietic Progenitor Cells Transplantation Supply, Demand and Key Producers, 2023-2029

Page: 110

Published Date: 19 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Hematopoietic Progenitor Cells Transplantation market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Hematopoietic Progenitor Cells Transplantation demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hematopoietic Progenitor Cells Transplantation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hematopoietic Progenitor Cells Transplantation that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hematopoietic Progenitor Cells Transplantation total market, 2018-2029, (USD Million)
Global Hematopoietic Progenitor Cells Transplantation total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Hematopoietic Progenitor Cells Transplantation total market, key domestic companies and share, (USD Million)
Global Hematopoietic Progenitor Cells Transplantation revenue by player and market share 2018-2023, (USD Million)
Global Hematopoietic Progenitor Cells Transplantation total market by Type, CAGR, 2018-2029, (USD Million)
Global Hematopoietic Progenitor Cells Transplantation total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Hematopoietic Progenitor Cells Transplantation market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies, Vcanbio, Merck Millipore, Lonza Group and CellGenix Technologie Transfer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hematopoietic Progenitor Cells Transplantation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Hematopoietic Progenitor Cells Transplantation Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hematopoietic Progenitor Cells Transplantation Market, Segmentation by Type
Hematopoietic Progenitor Cell Storage
Hematopoietic Progenitor Cells Consumables

Global Hematopoietic Progenitor Cells Transplantation Market, Segmentation by Application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders

Companies Profiled:
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis

Key Questions Answered
1. How big is the global Hematopoietic Progenitor Cells Transplantation market?
2. What is the demand of the global Hematopoietic Progenitor Cells Transplantation market?
3. What is the year over year growth of the global Hematopoietic Progenitor Cells Transplantation market?
4. What is the total value of the global Hematopoietic Progenitor Cells Transplantation market?
5. Who are the major players in the global Hematopoietic Progenitor Cells Transplantation market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Hematopoietic Progenitor Cells Transplantation Introduction
1.2 World Hematopoietic Progenitor Cells Transplantation Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Hematopoietic Progenitor Cells Transplantation Total Market by Region (by Headquarter Location)
1.3.1 World Hematopoietic Progenitor Cells Transplantation Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.3 China Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.4 Europe Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.5 Japan Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.6 South Korea Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.7 ASEAN Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.3.8 India Hematopoietic Progenitor Cells Transplantation Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hematopoietic Progenitor Cells Transplantation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hematopoietic Progenitor Cells Transplantation Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.2 World Hematopoietic Progenitor Cells Transplantation Consumption Value by Region
2.2.1 World Hematopoietic Progenitor Cells Transplantation Consumption Value by Region (2018-2023)
2.2.2 World Hematopoietic Progenitor Cells Transplantation Consumption Value Forecast by Region (2024-2029)
2.3 United States Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.4 China Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.5 Europe Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.6 Japan Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.7 South Korea Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.8 ASEAN Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)
2.9 India Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029)

3 World Hematopoietic Progenitor Cells Transplantation Companies Competitive Analysis
3.1 World Hematopoietic Progenitor Cells Transplantation Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Hematopoietic Progenitor Cells Transplantation Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Hematopoietic Progenitor Cells Transplantation in 2022
3.2.3 Global Concentration Ratios (CR8) for Hematopoietic Progenitor Cells Transplantation in 2022
3.3 Hematopoietic Progenitor Cells Transplantation Company Evaluation Quadrant
3.4 Hematopoietic Progenitor Cells Transplantation Market: Overall Company Footprint Analysis
3.4.1 Hematopoietic Progenitor Cells Transplantation Market: Region Footprint
3.4.2 Hematopoietic Progenitor Cells Transplantation Market: Company Product Type Footprint
3.4.3 Hematopoietic Progenitor Cells Transplantation Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Hematopoietic Progenitor Cells Transplantation Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Hematopoietic Progenitor Cells Transplantation Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Hematopoietic Progenitor Cells Transplantation Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Hematopoietic Progenitor Cells Transplantation Consumption Value Comparison
4.2.1 United States VS China: Hematopoietic Progenitor Cells Transplantation Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hematopoietic Progenitor Cells Transplantation Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Hematopoietic Progenitor Cells Transplantation Companies and Market Share, 2018-2023
4.3.1 United States Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023)
4.4 China Based Companies Hematopoietic Progenitor Cells Transplantation Revenue and Market Share, 2018-2023
4.4.1 China Based Hematopoietic Progenitor Cells Transplantation Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023)
4.5 Rest of World Based Hematopoietic Progenitor Cells Transplantation Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Hematopoietic Progenitor Cells Transplantation Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hematopoietic Progenitor Cell Storage
5.2.2 Hematopoietic Progenitor Cells Consumables
5.3 Market Segment by Type
5.3.1 World Hematopoietic Progenitor Cells Transplantation Market Size by Type (2018-2023)
5.3.2 World Hematopoietic Progenitor Cells Transplantation Market Size by Type (2024-2029)
5.3.3 World Hematopoietic Progenitor Cells Transplantation Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Hematopoietic Progenitor Cells Transplantation Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Leukemia
6.2.2 Lymphoproliferative Disorders
6.2.3 Solid Tumors
6.2.4 Non-Malignant Disorders
6.2.5 Non-Malignant Disorders
6.3 Market Segment by Application
6.3.1 World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2018-2023)
6.3.2 World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2024-2029)
6.3.3 World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2018-2029)

7 Company Profiles
7.1 CBR Systems
7.1.1 CBR Systems Details
7.1.2 CBR Systems Major Business
7.1.3 CBR Systems Hematopoietic Progenitor Cells Transplantation Product and Services
7.1.4 CBR Systems Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 CBR Systems Recent Developments/Updates
7.1.6 CBR Systems Competitive Strengths & Weaknesses
7.2 China Cord Blood Corporation
7.2.1 China Cord Blood Corporation Details
7.2.2 China Cord Blood Corporation Major Business
7.2.3 China Cord Blood Corporation Hematopoietic Progenitor Cells Transplantation Product and Services
7.2.4 China Cord Blood Corporation Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 China Cord Blood Corporation Recent Developments/Updates
7.2.6 China Cord Blood Corporation Competitive Strengths & Weaknesses
7.3 ViaCord
7.3.1 ViaCord Details
7.3.2 ViaCord Major Business
7.3.3 ViaCord Hematopoietic Progenitor Cells Transplantation Product and Services
7.3.4 ViaCord Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 ViaCord Recent Developments/Updates
7.3.6 ViaCord Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Hematopoietic Progenitor Cells Transplantation Product and Services
7.4.4 Thermo Fisher Scientific Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 STEMCELL Technologies
7.5.1 STEMCELL Technologies Details
7.5.2 STEMCELL Technologies Major Business
7.5.3 STEMCELL Technologies Hematopoietic Progenitor Cells Transplantation Product and Services
7.5.4 STEMCELL Technologies Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 STEMCELL Technologies Recent Developments/Updates
7.5.6 STEMCELL Technologies Competitive Strengths & Weaknesses
7.6 Vcanbio
7.6.1 Vcanbio Details
7.6.2 Vcanbio Major Business
7.6.3 Vcanbio Hematopoietic Progenitor Cells Transplantation Product and Services
7.6.4 Vcanbio Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Vcanbio Recent Developments/Updates
7.6.6 Vcanbio Competitive Strengths & Weaknesses
7.7 Merck Millipore
7.7.1 Merck Millipore Details
7.7.2 Merck Millipore Major Business
7.7.3 Merck Millipore Hematopoietic Progenitor Cells Transplantation Product and Services
7.7.4 Merck Millipore Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Millipore Recent Developments/Updates
7.7.6 Merck Millipore Competitive Strengths & Weaknesses
7.8 Lonza Group
7.8.1 Lonza Group Details
7.8.2 Lonza Group Major Business
7.8.3 Lonza Group Hematopoietic Progenitor Cells Transplantation Product and Services
7.8.4 Lonza Group Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Lonza Group Recent Developments/Updates
7.8.6 Lonza Group Competitive Strengths & Weaknesses
7.9 CellGenix Technologie Transfer
7.9.1 CellGenix Technologie Transfer Details
7.9.2 CellGenix Technologie Transfer Major Business
7.9.3 CellGenix Technologie Transfer Hematopoietic Progenitor Cells Transplantation Product and Services
7.9.4 CellGenix Technologie Transfer Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 CellGenix Technologie Transfer Recent Developments/Updates
7.9.6 CellGenix Technologie Transfer Competitive Strengths & Weaknesses
7.10 ThermoGenesis
7.10.1 ThermoGenesis Details
7.10.2 ThermoGenesis Major Business
7.10.3 ThermoGenesis Hematopoietic Progenitor Cells Transplantation Product and Services
7.10.4 ThermoGenesis Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 ThermoGenesis Recent Developments/Updates
7.10.6 ThermoGenesis Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Hematopoietic Progenitor Cells Transplantation Industry Chain
8.2 Hematopoietic Progenitor Cells Transplantation Upstream Analysis
8.3 Hematopoietic Progenitor Cells Transplantation Midstream Analysis
8.4 Hematopoietic Progenitor Cells Transplantation Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Hematopoietic Progenitor Cells Transplantation Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Hematopoietic Progenitor Cells Transplantation Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Hematopoietic Progenitor Cells Transplantation Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Hematopoietic Progenitor Cells Transplantation Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Hematopoietic Progenitor Cells Transplantation Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Hematopoietic Progenitor Cells Transplantation Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Hematopoietic Progenitor Cells Transplantation Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Hematopoietic Progenitor Cells Transplantation Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Hematopoietic Progenitor Cells Transplantation Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Hematopoietic Progenitor Cells Transplantation Players in 2022
Table 12. World Hematopoietic Progenitor Cells Transplantation Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Hematopoietic Progenitor Cells Transplantation Company Evaluation Quadrant
Table 14. Head Office of Key Hematopoietic Progenitor Cells Transplantation Player
Table 15. Hematopoietic Progenitor Cells Transplantation Market: Company Product Type Footprint
Table 16. Hematopoietic Progenitor Cells Transplantation Market: Company Product Application Footprint
Table 17. Hematopoietic Progenitor Cells Transplantation Mergers & Acquisitions Activity
Table 18. United States VS China Hematopoietic Progenitor Cells Transplantation Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Hematopoietic Progenitor Cells Transplantation Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (States, Country)
Table 21. United States Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Hematopoietic Progenitor Cells Transplantation Revenue Market Share (2018-2023)
Table 23. China Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (Province, Country)
Table 24. China Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Hematopoietic Progenitor Cells Transplantation Revenue Market Share (2018-2023)
Table 26. Rest of World Based Hematopoietic Progenitor Cells Transplantation Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Hematopoietic Progenitor Cells Transplantation Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Hematopoietic Progenitor Cells Transplantation Revenue Market Share (2018-2023)
Table 29. World Hematopoietic Progenitor Cells Transplantation Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Hematopoietic Progenitor Cells Transplantation Market Size by Type (2018-2023) & (USD Million)
Table 31. World Hematopoietic Progenitor Cells Transplantation Market Size by Type (2024-2029) & (USD Million)
Table 32. World Hematopoietic Progenitor Cells Transplantation Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2018-2023) & (USD Million)
Table 34. World Hematopoietic Progenitor Cells Transplantation Market Size by Application (2024-2029) & (USD Million)
Table 35. CBR Systems Basic Information, Area Served and Competitors
Table 36. CBR Systems Major Business
Table 37. CBR Systems Hematopoietic Progenitor Cells Transplantation Product and Services
Table 38. CBR Systems Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. CBR Systems Recent Developments/Updates
Table 40. CBR Systems Competitive Strengths & Weaknesses
Table 41. China Cord Blood Corporation Basic Information, Area Served and Competitors
Table 42. China Cord Blood Corporation Major Business
Table 43. China Cord Blood Corporation Hematopoietic Progenitor Cells Transplantation Product and Services
Table 44. China Cord Blood Corporation Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. China Cord Blood Corporation Recent Developments/Updates
Table 46. China Cord Blood Corporation Competitive Strengths & Weaknesses
Table 47. ViaCord Basic Information, Area Served and Competitors
Table 48. ViaCord Major Business
Table 49. ViaCord Hematopoietic Progenitor Cells Transplantation Product and Services
Table 50. ViaCord Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. ViaCord Recent Developments/Updates
Table 52. ViaCord Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Hematopoietic Progenitor Cells Transplantation Product and Services
Table 56. Thermo Fisher Scientific Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. STEMCELL Technologies Basic Information, Area Served and Competitors
Table 60. STEMCELL Technologies Major Business
Table 61. STEMCELL Technologies Hematopoietic Progenitor Cells Transplantation Product and Services
Table 62. STEMCELL Technologies Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. STEMCELL Technologies Recent Developments/Updates
Table 64. STEMCELL Technologies Competitive Strengths & Weaknesses
Table 65. Vcanbio Basic Information, Area Served and Competitors
Table 66. Vcanbio Major Business
Table 67. Vcanbio Hematopoietic Progenitor Cells Transplantation Product and Services
Table 68. Vcanbio Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Vcanbio Recent Developments/Updates
Table 70. Vcanbio Competitive Strengths & Weaknesses
Table 71. Merck Millipore Basic Information, Area Served and Competitors
Table 72. Merck Millipore Major Business
Table 73. Merck Millipore Hematopoietic Progenitor Cells Transplantation Product and Services
Table 74. Merck Millipore Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Merck Millipore Recent Developments/Updates
Table 76. Merck Millipore Competitive Strengths & Weaknesses
Table 77. Lonza Group Basic Information, Area Served and Competitors
Table 78. Lonza Group Major Business
Table 79. Lonza Group Hematopoietic Progenitor Cells Transplantation Product and Services
Table 80. Lonza Group Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Lonza Group Recent Developments/Updates
Table 82. Lonza Group Competitive Strengths & Weaknesses
Table 83. CellGenix Technologie Transfer Basic Information, Area Served and Competitors
Table 84. CellGenix Technologie Transfer Major Business
Table 85. CellGenix Technologie Transfer Hematopoietic Progenitor Cells Transplantation Product and Services
Table 86. CellGenix Technologie Transfer Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. CellGenix Technologie Transfer Recent Developments/Updates
Table 88. ThermoGenesis Basic Information, Area Served and Competitors
Table 89. ThermoGenesis Major Business
Table 90. ThermoGenesis Hematopoietic Progenitor Cells Transplantation Product and Services
Table 91. ThermoGenesis Hematopoietic Progenitor Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Hematopoietic Progenitor Cells Transplantation Upstream (Raw Materials)
Table 93. Hematopoietic Progenitor Cells Transplantation Typical Customers
List of Figure
Figure 1. Hematopoietic Progenitor Cells Transplantation Picture
Figure 2. World Hematopoietic Progenitor Cells Transplantation Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hematopoietic Progenitor Cells Transplantation Total Market Size (2018-2029) & (USD Million)
Figure 4. World Hematopoietic Progenitor Cells Transplantation Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Hematopoietic Progenitor Cells Transplantation Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Hematopoietic Progenitor Cells Transplantation Revenue (2018-2029) & (USD Million)
Figure 13. Hematopoietic Progenitor Cells Transplantation Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 16. World Hematopoietic Progenitor Cells Transplantation Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 18. China Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 23. India Hematopoietic Progenitor Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Hematopoietic Progenitor Cells Transplantation by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Hematopoietic Progenitor Cells Transplantation Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Hematopoietic Progenitor Cells Transplantation Markets in 2022
Figure 27. United States VS China: Hematopoietic Progenitor Cells Transplantation Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hematopoietic Progenitor Cells Transplantation Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Hematopoietic Progenitor Cells Transplantation Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Hematopoietic Progenitor Cells Transplantation Market Size Market Share by Type in 2022
Figure 31. Hematopoietic Progenitor Cell Storage
Figure 32. Hematopoietic Progenitor Cells Consumables
Figure 33. World Hematopoietic Progenitor Cells Transplantation Market Size Market Share by Type (2018-2029)
Figure 34. World Hematopoietic Progenitor Cells Transplantation Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Hematopoietic Progenitor Cells Transplantation Market Size Market Share by Application in 2022
Figure 36. Leukemia
Figure 37. Lymphoproliferative Disorders
Figure 38. Solid Tumors
Figure 39. Non-Malignant Disorders
Figure 40. Hematopoietic Progenitor Cells Transplantation Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now